New tools for the evaluation of toxic ocular surface changes in the rat

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 12, 2007, Pages 5473-5483

  Pauly, Aude ^a,b   Brignole Baudouin, Françoise ^a,b   Labbé, Antoine ^a,c   Liang, Hong ^a,c   Warnet, Jean Michel ^a,b   Baudouin, Christophe ^a,c,d  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; FLUORESCENT DYE; PRESERVATIVE; BENZALKONIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL ASSESSMENT TOOL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA; CORNEA EPITHELIUM; CORNEA NEOVASCULARIZATION; CORNEA THICKNESS; CYTOLOGY; EYE EXAMINATION; EYE INJURY; EYE IRRITATION; EYE TOXICITY; FLOW CYTOMETRY; GOBLET CELL; HISTOLOGY; IMMUNOFLUORESCENCE TEST; IMPRESSION CYTOLOGY; IN VIVO STUDY; KERATITIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SLIT LAMP; ANIMAL; CONJUNCTIVA; DISEASE MODEL; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; LEWIS RAT; PATHOLOGY; TOXICITY TESTING;

ANIMALS; BENZALKONIUM COMPOUNDS; CONJUNCTIVA; CORNEA; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MALE; MICROSCOPY, CONFOCAL; PRESERVATIVES, PHARMACEUTICAL; RATS; RATS, INBRED LEW; TOXICITY TESTS;

EID: 34447628149     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0728     Document Type: Article

References (51)

1. Draize JH, Woodward G, Calvery HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377-390.
2. Freeberg FE, Nixon GA, Reer PJ, et al. Human and rabbit eye responses to chemical insult. Fundam Appl Toxicol. 1986;7:626-634.
3. Bruner LH. Alternatives to the use of animals in household product and cosmetic testing. J Am Vet Med Assoc. 1992;200:669-673.
4. Griffith JF, Nixon GA, Bruce RD, Reer PJ, Barman EA. Dose-response studies with chemical irritants in the albino rabbit eye as a basis for selecting optimum testing conditions for predicting hazard to the human eye. Toxicol Appl Pharmacol. 1980;55:501-513.
5. York M, Steiling W. A critical review of the assessment of eye irritation potential using the Draize rabbit eye test. J Appl Toxicol. 1998;18:233-240.
6. Rohde BH. In vitro methods in ophthalmic toxicology. In: Chiou GCY, ed. Ophthalmic Toxicology. New York: Raven Press; 1997: 109-165.
7. Chu IH, Toft P. Recent progress in the eye irritation test. Toxicol Ind Health. 1993;9:1017-1025.
8. Adolphe M. Alternative methods to animal experimentation. Scientific and ethical problems (in French). Bull Acad Natl Med. 1995;179:1009-1016; discussion 1116-1119.
9. Bruner LH. Ocular irritation. In: Frazier JM, ed. In Vitro Toxicity Testing. Application to Safety Evaluation. New York: Marcel Dekker; 1992:149-190.
10. Lilja J, Forsby A. Development of a sensory neuronal cell model for the estimation of mild eye irritation. Altern Lab Anim. 2004;32: 339-343.
11. Furrer P, Plazonnet B, Mayer JM, Gurny R. Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. Int J Pharm. 2000;207:89-98.
12. Burton AB. A method for the objective assessment of eye irritation. Food Cosmet Toxicol. 1972;10:209-217.
13. Ballantyne B, Swanston DW. Ocular irritation tests. Br J Pharmacol 1972;46:577P-578P.
14. Burstein NL, Klyce SD. Electrophysiologic and morphologic effects of ophthalmic preparations on rabbit cornea epithelium. Invest Ophthalmol Vis Sci. 1977;16:899-911.
15. Kovoor TA, Kim AS, McCulley JP, et al. Evaluation of the corneal effects of topical ophthalmic fluoroquinolones using in vivo confocal microscopy. Eye Contact Lens. 2004;30:90-94.
16. Jester JV, Petroll WM, Bean J, et al. Area and depth of surfactant-induced corneal injury predicts extent of subsequent ocular responses. Invest Ophthalmol Vis Sci. 1998;39:2610-2625.
17. Jester JV, Li HF, Petroll WM, et al. Area and depth of surfactant-induced corneal injury correlates with cell death. Invest Ophthalmol Vis Sci. 1998;39:922-936.
18. Ichijima H, Petroll WM, Jester JV, Cavanagh HD. Confocal microscopic studies of living rabbit cornea treated with benzalkonium chloride. Cornea. 1992;11:221-225.
19. Maurer JK, Jester JV. Use of in vivo confocal microscopy to understand the pathology of accidental ocular irritation. Toxicol Pathol. 1999;27:44-47.
20. Maurer JK, Parker RD, Petroll WM, et al. Quantitative measurement of acute corneal injury in rabbits with surfactants of different type and irritancy. Toxicol Appl Pharmacol. 1999;158:61-70.
21. Russell WMS, Burch RL. The Principles of Humane Care in Experimental Technique. London: Methuen; 1959.
22. Pisella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res. 2000;32:3-8.
23. Noecker RJ, Herrygers LA, Anwaruddin R. Corneal and conjunctival changes caused by commonly used glaucoma medications. Cornea. 2004;23:490-496.
24. Swan KC. Reactivity of the ocular tissues to wetting agents. Am J Ophthalmol. 1944;27:1118-1122.
25. Becquet F, Goldschild M, Moldovan MS, et al. Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res. 1998;17:419-425.
26. Burstein NL. Preservative cytotoxic threshold for benzalkonium chloride and chlorhexidine digluconate in cat and rabbit corneas. Invest Ophthalmol Vis Sci. 1980;19:308-313.
27. Baudouin C, Hamard P, Liang H, et al. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology. 2004;111: 2186-2192.
28. Gasset AR. Benzalkonium chloride toxicity to the human cornea. Am J Ophthalmol. 1977;84:169-171.
29. De Saint Jean M, Brignole F, Bringuier AF, et al. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci. 1999;40:619-630.
30. Debbasch C, Pisella PJ, De Saint Jean M, et al. Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells. Invest Ophthalmol Vis Sci. 2001;42:2525-2533.
31. Debbasch C, Brignole F, Pisella PJ, et al. Quaternary ammoniums and other preservatives' contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci. 2001;42:642-652.
32. Guenoun JM, Baudouin C, Rat P, et al. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci. 2005;46:2444-2450.
33. Mietz H, Niesen U, Krieglstein GK. The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefes Arch Clin Exp Ophthalmol. 1994;232:561-565.
34. Pisella PJ, Debbasch C, Hamard P, et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci. 2004;45:1360-1368.
35. Labbe A, Dupas B, Hamard P, Baudouin C. In vivo confocal microscopy study of blebs after filtering surgery. Ophthalmology. 2005;112:1979.
36. Labbe A, Liang H, Martin C, et al. Comparative anatomy of laboratory animal corneas with a new-generation high-resolution in vivo confocal microscope. Curr Eye Res. 2006;31:501-509.
37. Jester JV, Maurer JK, Petroll WM, et al. Application of in vivo confocal microscopy to the understanding of surfactant-induced ocular irritation. Toxicol Pathol. 1996;24:412-428.
38. Brignole F, Pisella PJ, Goldschild M, et al. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356-1363.
39. Bara J, Gautier R, Daher N, Zaghouani H, Decaens C. Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae. Cancer Res. 1986;46: 3983-3989.
40. Fujihara T, Takeuchi T, Saito K, et al. Evaluation of human conjunctival epithelium by a combination of brush cytology and flow cytometry: an approach to the quantitative technique. Diagn Cytopathol. 1997;17:456-460.
41. Ormerod MG, Collins MK, Rodriguez-Tarduchy G, Robertson D. Apoptosis in interleukin-3-dependent haemopoietic cells: quantification by two flow cytometric methods. J Immunol Methods. 1992;153:57-65.
42. Maurer JK, Parker RD. Light microscopic comparison of surfactant-induced eye irritation in rabbits and rats at three hours and recovery/day 35. Toxicol Pathol. 1996;24:403-411.
43. Jester JV, Molai A, Petroll WM, et al. Quantitative characterization of acid- and alkali-induced corneal injury in the low-volume eye test. Toxicol Pathol. 2000;28:668-678.
44. Bochert R, Zhivov A, Kraak R, Stave J, Guthoff RF. Contribution to comprehension of image formation in confocal microscopy of cornea with Rostock cornea module. Br J Ophthalmol. 2005;89: 1351-1355.
45. Labbe A, Dupas B, Hamard P, Baudouin C. An evaluation of blebs after filtering surgery with the in vivo confocal microscope (in French). J Fr Ophtalmol. 2004;27:1083-1089.
46. Egbert PR, Lauber S, Maurice DM. A simple conjunctival biopsy. Am J Ophthalmol. 1977;84:798-801.
47. Baudouin C, Liang H, Bremond-Gignac D, et al. CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/T(H)2 in ocular surface disorders. J Allergy Clin Immunol. 2005;116:614-619.
48. Kinoshita S, Kiorpes TC, Friend J, Thoft RA. Goblet cell density in ocular surface disease: a better indicator than tear mucin. Arch Ophthalmol. 1983;101:1284-1287.
49. Dogru M, Asano-Kato N, Tanaka M, et al. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res. 2005;30:897-908.
50. Adams GG, Dilly PN, Kirkness CM. Monitoring ocular disease by impression cytology. Eye. 1988;2:506-516.
51. Leonardi A, Curnow SJ, Zhan H and Calder VL. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy. 2006;36:777-784.